<DOC>
	<DOCNO>NCT02394873</DOCNO>
	<brief_summary>This phase I study evaluate safety ALLO-ASC-DFU treatment deep second-degree burn wound patient . ALLO-ASC-DFU hydrogel sheet contain allogenic adipose-derived mesenchymal stem cell . Adipose-derived stem cell release growth factor vascular endothelial growth factor ( VEGF ) hepatocyte growth factor ( HGF ) , enhance wound heal regeneration new tissue , finally may provide new option treat burn .</brief_summary>
	<brief_title>A Study Evaluate Safety ALLO-ASC-DFU Subjects With Deep Second-degree Burn Wound</brief_title>
	<detailed_description />
	<mesh_term>Burns</mesh_term>
	<criteria>1 . Subject 18 year age old . 2 . Subjects deep seconddegree burn â‰¥100 cm^2 . 3 . Negative urine betaHCG woman childbearing age . 4 . Subject able give write informed consent prior study start comply study requirement . 1 . Subjects enrol another clinical study within 30 day screen . 2 . Subjects allergic hypersensitive reaction bovinederived protein fibrin glue . 3 . Subjects receive steroid , immunosuppressive , anticoagulant . 4 . Subjects active infection . 5 . Subjects hemorrhagic hemocoagulative disease 6 . Subjects unwilling use `` effective '' method contraception study . 7 . Subjects history malignant tumor within last five year , currently undergo . 8 . Subjects pregnant breastfeeding . 9 . Subjects consider significant disease impact study investigator 10 . Burn wound present part face . 11 . Subjects history surgery malignant tumor within last five year ( except carcinoma site ) . 12 . Subjects consider suitable study investigator . 13 . Subjects able understand objective study comply study requirement .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Deep Second-Degree Burn Wound</keyword>
</DOC>